Literature DB >> 21248688

Testing protozoacidal activity of ligand-lytic peptides against termite gut protozoa in vitro (protozoa culture) and in vivo (microinjection into termite hindgut).

Claudia Husseneder1, Amit Sethi, Lane Foil, Jennifer Delatte.   

Abstract

We are developing a novel approach to subterranean termite control that would lead to reduced reliance on the use of chemical pesticides. Subterranean termites are dependent on protozoa in the hindguts of workers to efficiently digest wood. Lytic peptides have been shown to kill a variety of protozoan parasites (Mutwiri et al. 2000) and also protozoa in the gut of the Formosan subterranean termite, Coptotermes formosanus (Husseneder and Collier 2009). Lytic peptides are part of the nonspecific immune system of eukaryotes, and destroy the membranes of microorganisms (Leuschner and Hansel 2004). Most lytic peptides are not likely to harm higher eukaryotes, because they do not affect the electrically neutral cholesterol-containing cell membranes of higher eukaryotes (Javadpour et al. 1996). Lytic peptide action can be targeted to specific cell types by the addition of a ligand. For example, Hansel et al. (2007) reported that lytic peptides conjugated with cancer cell membrane receptor ligands could be used to destroy breast cancer cells, while lytic peptides alone or conjugated with non-specific peptides were not effective. Lytic peptides also have been conjugated to human hormones that bind to receptors on tumor cells for targeted destruction of prostate and testicular cancer cells (Leuschner and Hansel 2004). In this article we present techniques used to demonstrate the protozoacidal activity of a lytic peptide (Hecate) coupled to a heptapeptide ligand that binds to the surface membrane of protozoa from the gut of the Formosan subterranean termite. These techniques include extirpation of the gut from termite workers, anaerobic culture of gut protozoa (Pseudotrichonympha grassii, Holomastigotoides hartmanni,Spirotrichonympha leidyi), microscopic confirmation that the ligand marked with a fluorescent dye binds to the termite gut protozoa and other free-living protozoa but not to bacteria or gut tissue. We also demonstrate that the same ligand coupled to a lytic peptide efficiently kills termite gut protozoa in vitro (protozoa culture) and in vivo (microinjection into hindgut of workers), but is less bacteriacidal than the lytic peptide alone. The loss of protozoa leads to the death of the termites in less than two weeks. In the future, we will genetically engineer microorganisms that can survive in the termite hindgut and spread through a termite colony as "Trojan Horses" to express ligand-lytic peptides that would kill the protozoa in the termite gut and subsequently kill the termites in the colony. Ligand-lytic peptides also could be useful for drug development against protozoan parasites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21248688      PMCID: PMC3159646          DOI: 10.3791/2190

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  Use of genetically engineered Escherichia coli to monitor ingestion, loss, and transfer of bacteria in termites.

Authors:  C Husseneder; J K Grace; D E Oishi
Journal:  Curr Microbiol       Date:  2005-02-03       Impact factor: 2.188

2.  Effect of the antimicrobial peptide, D-hecate, on trichomonads.

Authors:  G K Mutwiri; W G Henk; F M Enright; L B Corbeil
Journal:  J Parasitol       Date:  2000-12       Impact factor: 1.276

Review 3.  Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.

Authors:  William Hansel; Carola Leuschner; Fred Enright
Journal:  Mol Cell Endocrinol       Date:  2007-02-15       Impact factor: 4.102

4.  De novo antimicrobial peptides with low mammalian cell toxicity.

Authors:  M M Javadpour; M M Juban; W C Lo; S M Bishop; J B Alberty; S M Cowell; C L Becker; M L McLaughlin
Journal:  J Med Chem       Date:  1996-08-02       Impact factor: 7.446

5.  Genetically engineered termite gut bacteria (Enterobacter cloacae) deliver and spread foreign genes in termite colonies.

Authors:  Claudia Husseneder; J Kenneth Grace
Journal:  Appl Microbiol Biotechnol       Date:  2005-03-02       Impact factor: 4.813

Review 6.  Membrane disrupting lytic peptides for cancer treatments.

Authors:  Carola Leuschner; William Hansel
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

  6 in total
  3 in total

1.  Genetically Engineered Yeast Expressing a Lytic Peptide from Bee Venom (Melittin) Kills Symbiotic Protozoa in the Gut of Formosan Subterranean Termites.

Authors:  Claudia Husseneder; Jennifer R Donaldson; Lane D Foil
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

2.  Assessment of genetically engineered Trabulsiella odontotermitis as a 'Trojan Horse' for paratransgenesis in termites.

Authors:  Chinmay Vijay Tikhe; Thomas M Martin; Andréa Howells; Jennifer Delatte; Claudia Husseneder
Journal:  BMC Microbiol       Date:  2016-09-05       Impact factor: 3.605

3.  Protozoacidal Trojan-Horse: use of a ligand-lytic peptide for selective destruction of symbiotic protozoa within termite guts.

Authors:  Amit Sethi; Jennifer Delatte; Lane Foil; Claudia Husseneder
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.